25 unknown. 25 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 25 | Unknown 25 |
| Phase 1 | 2 | Unknown 2 |
| Phase 3 | 2 | Unknown 2 |
Follow Bronchiolitis: new trials by email Literature Review of Bronchiolitis trials Research Report on Bronchiolitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome Ruxolitinib - Bronchiolitis Obliterans Syndrome, Hematologic Malignancy | Phase 2 | Unknown | First Affiliated Hospital of Zhejiang University | 50 | 2022-06-01 | 2022-10-19 |
| Efficacy and Safety of Low-dose Ibrutinib and Itraconazole in Chronic Graft Versus Host Disease Low-dose ibrutinib - Chronic Graft-versus-host-disease | Phase 2 | Unknown | Hospital Universitario Dr. Jose E. Gonzalez | 13 | 2022-04-01 | 2022-04-27 |
| A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia Orelabrutinib( lower dose), Orelabrutinib( higher dose) - Primary Immune Thrombocytopenia | Phase 2 | Unknown | Beijing InnoCare Pharma Tech Co., Ltd. | 30 | 2022-02-21 | 2023-01-12 |
| MSC for Treatment of cGVHD After Allo-HSCT Mesenchymal stem cells, Glucocorticoids, cyclosporine - Chronic Graft-versus-host Disease | Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 152 | 2021-01-10 | 2020-12-31 |
| Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia Ponatinib - Chronic Myeloid Leukemia | Phase 2 | Unknown | Fundación Teófilo Hernando, Spain | 40 | 2019-04-30 | 2019-08-02 |
| BENDITA BEnznidazole New Doses Improved Treatment and Associations Benznidazole, E1224, E1224 Placebo - Chagas Disease | Phase 2 | Unknown | Drugs for Neglected Diseases | 210 | 2016-11-30 | 2017-12-20 |
| Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease SCM-CGH, Placebo - Chronic Graft-versus-host-disease | Phase 2 | Unknown | SCM Lifescience Co., LTD. | 84 | 2016-09-28 | 2023-06-08 |
| Epinephrine, Dexamethasone and Hypertonic Saline in Bronchiolitis Hypertonic Saline 3%, Epinephrine and Dexamethasone - Bronchiolitis | Phase 2 | Unknown | Hospital General Naval de Alta Especialidad - Escuela Medico Naval | 100 | 2015-11-01 | 2015-11-11 |
| MSC for Treatment of Interstitial Lung Disease After Allo-HSCT MSCs, AZM, Glucocorticoid - Lung Diseases, Interstitial, Hematopoietic Stem Cell Transplantation | Phase 1 / Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 60 | 2014-09-01 | 2017-05-10 |
| Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD) Photopheresis Theraflex ECP™ - Refractory Chronic Graft Versus Host Disease (cGVHD) | Phase 2 | Unknown | Jules Bordet Institute | 100 | 2014-09-01 | 2017-03-20 |
| Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart Failure intracoronary infusion of autologous bone marrow-derived cells - Heart Failure | Phase 2 / Phase 3 | Unknown | Johann Wolfgang Goethe University Hospital | 81 | 2013-11-01 | 2020-02-26 |
| Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease Mesenchymal stem cells, Non-mesenchymal stem cells - Chronic Graft-versus-host Disease | Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 60 | 2013-01-01 | 2013-01-10 |
| A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT Interferon gamma 1b - Steroid-refractory Bronchiolitis Obliterans | Phase 2 | Unknown | University Hospital Regensburg | 10 | 2012-07-01 | 2012-07-12 |
| Pancreatic Perfusion Using Secretin and MRI Secretin - Chronic Pancreatitis | Phase 1 / Phase 2 | Unknown | University of Nottingham | 15 | 2012-06-01 | 2016-02-18 |
| Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease Biological: mesenchymal stem cell, Cyclosporine and Glucocorticoid - Chronic Graft Versus Host Disease | Phase 2 / Phase 3 | Unknown | Chinese Academy of Medical Sciences | 100 | 2012-02-01 | 2012-08-03 |
| Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers CD4 DLI, No DLI - Graft Versus Host Disease, Leukemia | Phase 2 | Unknown | University College, London | 114 | 2011-11-01 | 2019-02-12 |
| Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD) Bortezomib - Chronic Graft-versus-host Disease | Phase 2 | Unknown | Baylor Research Institute | 25 | 2010-06-01 | 2016-01-18 |
| Laparoscopic Prostatectomy for Chronic Prostatitis laparoscopic prostatectomy - Prostatitis, Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Phase 2 | Unknown | The Krongrad Institute | 100 | 2008-10-01 | 2011-05-02 |
| Hypertonic Saline for Outpatient Bronchiolitis Inhalation of salbutamol diluted in hypertonic saline, Inhalation of salbutamol diluted in normal saline - Bronchiolitis, Respiratory Distress | Phase 2 | Unknown | University Diego Portales | 74 | 2008-06-01 | 2008-06-12 |
| Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease Rituximab - Steroid-Refractory Chronic GVHD | Phase 2 | Unknown | The Korean Society of Hematopoietic Stem Cell Transplantation | 42 | 2007-05-01 | 2009-02-24 |
Showing 20 of 25. Sign in to see all of them.
Bronchiolitis Obliterans Syndrome (21) · Leukemia (3) · Bronchiolitis Obliterans (2) · Graft vs Host Disease (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Pain (2) · Arthritis, Reactive (1) · Chagas Disease (1) · Complex Regional Pain Syndromes (1) · Dyspnea (1) · Heart Failure (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Ischemia (1)
Bronchial Diseases (25) · Bronchitis (25) · Lung Diseases (25) · Lung Diseases, Obstructive (25) · Respiratory Tract Diseases (25) · Bronchiolitis Obliterans (21) · Immune System Diseases (21) · Organizing Pneumonia (21) · Graft vs Host Disease (19) · Pathological Conditions, Signs and Symptoms (11) · Pathologic Processes (7) · Chronic Disease (5) · Disease Attributes (5) · Hematologic Diseases (5)
Glucocorticoids (3) · Cyclosporine (2) · Interferon-gamma (2) · Alemtuzumab (1) · Antirheumatic Agents (1) · Bortezomib (1) · Dexamethasone (1) · Dronabinol (1) · Electroacupuncture (1) · Epinephrine (1) · Infliximab (1) · Prodrugs (1) · Rituximab (1) · Saline Solution (1) · Saline Solution, Hypertonic (1)
Nanfang Hospital, Southern Medical University (3) · Baylor Research Institute (1) · Beijing InnoCare Pharma Tech Co., Ltd. (1) · Charite University, Berlin, Germany (1) · Chinese Academy of Medical Sciences (1) · Chronic Lymphocytic Leukemia Research Consortium (1) · Drugs for Neglected Diseases (1) · First Affiliated Hospital of Zhejiang University (1) · Fundación Teófilo Hernando, Spain (1) · Hong Kong Baptist University (1) · Hospital General Naval de Alta Especialidad - Escuela Medico Naval (1) · Hospital Universitario Dr. Jose E. Gonzalez (1) · Johann Wolfgang Goethe University Hospital (1) · Jules Bordet Institute (1) · Ludwig-Maximilians - University of Munich (1)
China (6) · Germany (4) · United States (3) · Mexico (2) · South Korea (2) · United Kingdom (2) · Austria (1) · Belgium (1) · Bolivia (1) · Chile (1) · Spain (1)
Alan Miller, MD, PhD (1) · Andreas M Zeiher, MD (1) · Antonio Jimenez, Dr. (1) · Arnon Krongrad, MD (1) · Birgit Assmus, MD (1) · Blanca Xicoy, Dr. (1) · Chunhua Zhao, MD,PHD (1) · Ernst Holler, Professor MD (1) · Faustino Torrico, PhD (1) · Fermin Sanchez-Guijo, MD PhD (1) · Guillermo Orti, Dr. (1) · He Huang, MD (1) · Hildegard T Greinix, Professor of Medicine (1)
PMID 11756187, PMID 18827155, PMID 19047234, PMID 19439742, PMID 20100768, PMID 20399493, PMID 20634158, PMID 20965785, PMID 21471175, PMID 21978929, PMID 22270499, PMID 22579125, PMID 23047831, PMID 23114233, PMID 23440689, PMID 23481463, PMID 23704092, PMID 24166905, PMID 24323036, PMID 25138330, PMID 25344148, PMID 25349312, PMID 26178642, PMID 26686407, PMID 28218239, PMID 31260802, PMID 31664782, PMID 31668569, PMID 3295741, PMID 33836161, PMID 38485149, PMID 38546375, PMID 39627222, PMID 40982532
2017 (1)